YOKNEAM, Israel, Feb. 23, 2026 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) a leading global provider of innovative medical technologies ("InMode" or the "Company"), today announced that the independent ...

YOKNEAM, Israel - InMode Ltd. (NASDAQ:INMD), a provider of medical technologies, confirmed Monday it is evaluating potential strategic alternatives, following market speculation including a ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

InMode is rumored to be in advanced deal talks with a foreign investment fund, Calcalist, an Israeli newspaper reported this week. According to the report, the medical aesthetic device company could ...

YOKNEAM, Israel (AP) — YOKNEAM, Israel (AP) — InMode Ltd. (INMD) on Wednesday reported net income of $21.9 million in its third quarter. The Yokneam, Israel-based company said it had net income of 34 ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

InMode presents an appealing buy opportunity, trading near 52-week lows with strong fundamentals, innovative technology, and global expansion. INMD's minimally invasive platforms drive revenue growth, ...

YOKNEAM, Israel (AP) — YOKNEAM, Israel (AP) — InMode Ltd. (INMD) on Wednesday reported earnings of $26.7 million in its second quarter. On a per-share basis, the Yokneam, Israel-based company said it ...

YOKNEAM, Israel - InMode Ltd. (NASDAQ:INMD), a provider of medical technology currently valued at $919 million, responded to DOMA Perpetual Capital Management’s CEO Pedro Escudero regarding his ...

YOKNEAM, Israel, May 20, 2025 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, is pleased to announce Health Canada certification of IgniteRF, ...

InMode's Q4 revenue dropped YOY; management optimistic about new platforms despite industry challenges. High dependence on U.S. revenue from minimally invasive procedures; facing increasing ...